A carregar...
Levodopa-carbidopa enteral suspension in advanced Parkinson’s disease: clinical evidence and experience
The duration of action of oral levodopa becomes shorter as Parkinson’s disease (PD) progresses. Patients with advanced PD may develop potentially disabling motor fluctuations and abnormal involuntary movement (dyskinesia), which cannot be managed with optimized oral or transdermal PD medications. Th...
Na minha lista:
| Publicado no: | Ther Adv Neurol Disord |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
SAGE Publications
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5349373/ https://ncbi.nlm.nih.gov/pubmed/28344656 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756285616681280 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|